Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiaqi Han

Showing results (1-10 of 160) with videos related to

Pageof 16
Sort By:
Plos One|September 8, 2023
Research on the mechanism of promoting coordinated development of ecological well-being in rural counties through industrial transformationFan Yang, Wanlin Qi, Jiaqi Han
Heliyon|October 27, 2023
Digital Adoption levels and income generation in rural households in ChinaJiaqi Han, Jiayin Wang, Wenwu Zhang
Physical Review. E|October 19, 2024
Algebraic solitons in the massive Thirring modelJiaqi Han, Cheng He, Dmitry E Pelinovsky
Scientific Reports|November 3, 2022
LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysisYuxin Xie, Jiaqi Han, Keqi Xie, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|November 5, 2024
Automatic Landmark Detection for Preoperative Planning of High Tibial Osteotomy Using Traditional Feature Extraction and Deep Learning MethodsJiaqi Han, Xinlong Ma, Yiou Lyu, et al.
Oral Oncology|April 15, 2022
Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysisKun Tian, Jiaqi Han, Zhu Wang, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|April 16, 2026
Fast and Distributed Equivariant Graph Neural Networks by Virtual Node LearningYuelin Zhang, Jiacheng Cen, Jiaqi Han, et al.
Therapeutic Advances in Medical Oncology|May 25, 2023
Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancerJiangping Yang, Jiaqi Han, Ni Zeng, et al.
Plos One|May 21, 2024
Guaranteed minimum withdrawal benefits with high-water mark fee structureYichen Han, Lianxia Wu, Dongchen Li, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2020
Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-effectiveness analysisJiaqi Han, Kun Tian, Jiangping Yang, et al.
Pageof 16

Showing results (1-10 of 160) with videos related to

Sort By:
Pageof 16
Plos One|September 8, 2023
Research on the mechanism of promoting coordinated development of ecological well-being in rural counties through industrial transformationFan Yang, Wanlin Qi, Jiaqi Han
Heliyon|October 27, 2023
Digital Adoption levels and income generation in rural households in ChinaJiaqi Han, Jiayin Wang, Wenwu Zhang
Physical Review. E|October 19, 2024
Algebraic solitons in the massive Thirring modelJiaqi Han, Cheng He, Dmitry E Pelinovsky
Scientific Reports|November 3, 2022
LncRNAs as biomarkers for predicting radioresistance and survival in cancer: a meta-analysisYuxin Xie, Jiaqi Han, Keqi Xie, et al.
The International Journal of Medical Robotics + Computer Assisted Surgery : MRCAS|November 5, 2024
Automatic Landmark Detection for Preoperative Planning of High Tibial Osteotomy Using Traditional Feature Extraction and Deep Learning MethodsJiaqi Han, Xinlong Ma, Yiou Lyu, et al.
Oral Oncology|April 15, 2022
Immune checkpoint inhibition in first-line treatment for recurrent or metastatic nasopharyngeal carcinoma: A CAPTAIN-1st and JUPITER-02 trial-based cost-effectiveness analysisKun Tian, Jiaqi Han, Zhu Wang, et al.
IEEE Transactions on Pattern Analysis and Machine Intelligence|April 16, 2026
Fast and Distributed Equivariant Graph Neural Networks by Virtual Node LearningYuelin Zhang, Jiacheng Cen, Jiaqi Han, et al.
Therapeutic Advances in Medical Oncology|May 25, 2023
Cost-effectiveness of trastuzumab deruxtecan in previously treated human epidermal growth factor receptor 2-low metastatic breast cancerJiangping Yang, Jiaqi Han, Ni Zeng, et al.
Plos One|May 21, 2024
Guaranteed minimum withdrawal benefits with high-water mark fee structureYichen Han, Lianxia Wu, Dongchen Li, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2020
Durvalumab vs placebo consolidation therapy after chemoradiotherapy in stage III non-small-cell lung cancer: An updated PACIFIC trial-based cost-effectiveness analysisJiaqi Han, Kun Tian, Jiangping Yang, et al.
Pageof 16